Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125566183 | 12556618 | 3 | F | 20160222 | 20160822 | 20160714 | 20160829 | EXP | JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-37510NB | BOEHRINGER INGELHEIM | 82.00 | YR | M | Y | 68.80000 | KG | 20160829 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125566183 | 12556618 | 1 | PS | TRAZENTA | LINAGLIPTIN | 1 | Oral | 5 MG | Y | 201280 | 5 | MG | TABLET | QD | |||||
| 125566183 | 12556618 | 2 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | Y | 0 | ||||||||||
| 125566183 | 12556618 | 3 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 125566183 | 12556618 | 4 | C | TRESIBA | INSULIN DEGLUDEC | 1 | Subcutaneous | 20 U | 0 | 20 | IU | INJECTION | QD | ||||||
| 125566183 | 12556618 | 5 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 125566183 | 12556618 | 6 | C | METGLUCO | METFORMIN HYDROCHLORIDE | 1 | Oral | 750 MG | 0 | 250 | MG | TABLET | TID | ||||||
| 125566183 | 12556618 | 7 | C | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 0.9 MG | Y | 0 | .9 | MG | QD | ||||||
| 125566183 | 12556618 | 8 | C | TRULICITY | DULAGLUTIDE | 1 | Subcutaneous | 0.1071 U | 0 | .75 | IU | INJECTION | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125566183 | 12556618 | 1 | Type 2 diabetes mellitus |
| 125566183 | 12556618 | 2 | Product used for unknown indication |
| 125566183 | 12556618 | 3 | Hypertension |
| 125566183 | 12556618 | 4 | Type 2 diabetes mellitus |
| 125566183 | 12556618 | 5 | Hypertension |
| 125566183 | 12556618 | 6 | Type 2 diabetes mellitus |
| 125566183 | 12556618 | 7 | Type 2 diabetes mellitus |
| 125566183 | 12556618 | 8 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125566183 | 12556618 | OT |
| 125566183 | 12556618 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125566183 | 12556618 | Gastric ulcer | |
| 125566183 | 12556618 | Hyperglycaemia | |
| 125566183 | 12556618 | Hyperuricaemia | |
| 125566183 | 12556618 | Pemphigoid |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125566183 | 12556618 | 1 | 20150520 | 20160608 | 0 | |
| 125566183 | 12556618 | 2 | 20160510 | 0 | ||
| 125566183 | 12556618 | 3 | 20100302 | 0 | ||
| 125566183 | 12556618 | 4 | 20160223 | 0 | ||
| 125566183 | 12556618 | 5 | 20140617 | 0 | ||
| 125566183 | 12556618 | 6 | 20160223 | 0 | ||
| 125566183 | 12556618 | 7 | 20140617 | 20160309 | 0 | |
| 125566183 | 12556618 | 8 | 20160223 | 0 |